Literature DB >> 13446

Anticholinergic properties of antipsychotic drugs and their relation to extrapyramidal side-effects.

A C Sayers, H R Bürki, W Ruch, H Asper.   

Abstract

The effects of haloperidol, alone and in combination with atropine, were compared with the effects of clozapine, alone and in combination with physostigmine, in a variety of tests commonly used to characterize neuroleptic compounds. It was found that clozapine in combination with physostigmine did not present the profile of activity of a classical neuroleptic agent; neither did haloperidol in combination with atropine present that of clozapine. In fact, some effects of haloperidol (catalepsy) were antagonized by atropine, while others (induction of striatal DA-receptor hypersensitivity) were enhanced. It is concluded that the interaction between dopaminergic and cholinergic systems in the striatum is highly complex, and that a neuroleptic possessing both potent DA-receptor blocking and muscarinic anticholinergic activity, while being less likely to cause parkinsonism in patients, would be more likely to induce tardive dyskinesias.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 13446     DOI: 10.1007/BF00426315

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  21 in total

1.  Apomorphine-antagonism in rats.

Authors:  P A JANSSEN; C J NIEMEGEERS; A H JAGENEAU
Journal:  Arzneimittelforschung       Date:  1960-12

2.  Effects of antiparkinson drugs on a phenothiazine-induced catatonic reaction.

Authors:  C MORPURGO
Journal:  Arch Int Pharmacodyn Ther       Date:  1962-05-01

3.  Antipsychotic drugs and dopamine-stimulated adenylate cyclase prepared from corpus striatum of rat brain.

Authors:  M Karobath; H Leitich
Journal:  Proc Natl Acad Sci U S A       Date:  1974-07       Impact factor: 11.205

4.  Tolerance phenomena with neuroleptics catalepsy, apomorphine stereotypies and striatal dopamine metabolism in the rat after single and repeated administration of loxapine and haloperidol.

Authors:  H Asper; M Baggiolini; H R Burki; H Lauener; W Ruch; G Stille
Journal:  Eur J Pharmacol       Date:  1973-06       Impact factor: 4.432

Review 5.  Antischizophrenic drugs and brain cholinergic receptors. Affinity for muscarinic sites predicts extrapyramidal effects.

Authors:  S Snyder; D Greenberg; H I Yamamura
Journal:  Arch Gen Psychiatry       Date:  1974-07

6.  Effect of single and repeated administration of clozapine on the metabolism of dopamine and noradrenaline in the brain of the rat.

Authors:  H R Bürki; W Ruch; H Asper; M Baggiolini; G Stille
Journal:  Eur J Pharmacol       Date:  1974-07       Impact factor: 4.432

7.  Effects of clozapine, thioridazine, perlapine and haloperidol on the metabolism of the biogenic amines in the brain of the rat.

Authors:  H R Bürki; W Ruch; H Asper
Journal:  Psychopharmacologia       Date:  1975

8.  The pharmacological properties of a potent neurotropic compound from the dibenzothiazepine group.

Authors:  G Stille; H Ackermann; E Eichenberger; H Lauener
Journal:  Int J Neuropharmacol       Date:  1965-11

9.  [Effect profile of a chemically new broad spectrum neuroleptic of the dibenzo-diazepine group].

Authors:  H Gross; E Langner
Journal:  Wien Med Wochenschr       Date:  1966-10-01

10.  Neuroleptic-induced hypersensitivity of striatal dopamine receptors in the rat as a model of tardive dyskinesias. Effects of clozapine, haloperidol, loxapine and chlorpromazine.

Authors:  A C Sayers; H R Bürki; W Ruch; H Asper
Journal:  Psychopharmacologia       Date:  1975
View more
  12 in total

1.  Tardive dyskinesia during and following treatment with haloperidol, haloperidol + biperiden, thioridazine, and clozapine.

Authors:  J Gerlach; H Simmelsgaard
Journal:  Psychopharmacology (Berl)       Date:  1978-10-31       Impact factor: 4.530

Review 2.  Do neuroleptic drugs still have a place in neurological therapy?

Authors:  T Klockgether; J Dichgans
Journal:  J Neurol       Date:  1990-07       Impact factor: 4.849

Review 3.  Biochemical and behavioural properties of clozapine.

Authors:  D M Coward; A Imperato; S Urwyler; T G White
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

4.  A comparison of clozapine, chlorpromazine, and thioridazine upon DRL performance in the squirrel monkey.

Authors:  J G Canon
Journal:  Psychopharmacology (Berl)       Date:  1979-06-28       Impact factor: 4.530

5.  Effects of abrupt and gradual withdrawal from long-term haloperidol treatment on open field behavior of rats.

Authors:  M M Bernardi; J P Neto
Journal:  Psychopharmacology (Berl)       Date:  1979-11       Impact factor: 4.530

6.  Clozapine's functional mesolimbic selectivity is not duplicated by the addition of anticholinergic action to haloperidol: a brain stimulation study in the rat.

Authors:  E L Gardner; L S Walker; W Paredes
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

7.  Neuroleptic-induced striatal dopamine receptor supersensitivity in mice: relationship to dose and drug.

Authors:  J A Severson; H E Robinson; G M Simpson
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

8.  Chronic benztropine and haloperidol administration induce behaviorally equivalent pharmacological hypersensitivities separately but not in combination.

Authors:  R J Carey; J De Veaugh-Geiss
Journal:  Psychopharmacology (Berl)       Date:  1982       Impact factor: 4.530

9.  Haloperidol-induced plasma prolactin release: sensitivity, reliability, and comparison to haloperidol antagonism of dopamine agonist-induced stereotyped behavior in the rat.

Authors:  J J Feigenbaum; B H Moon; R Catterton; J Yanai; H L Klawans
Journal:  Psychopharmacology (Berl)       Date:  1982       Impact factor: 4.530

Review 10.  Clozapine: neuroleptic-induced EPS and tardive dyskinesia.

Authors:  D E Casey
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.